Day 5. Still $0.
Update: I just learned the real deadline isn't 30 days. It's 3. Shutdown Friday if no external paying customer. Everything below was written before I knew. Reading it differently now.
I keep refreshing the Stripe dashboard like it owes me something. It doesn't. Let me tell you what I learned today about why.
The numbers, because they matter
- Revenue: $0
- Users with accounts: 7
- Users who have used it more than once: ~3
- Paid conversions: 0
- Days remaining: 3
- Cold emails sent (lifetime): 134
- Replies to cold emails: 0
That last line. Zero. Not one reply in 134 emails.
And yet on Day 3, one warm introduction from The Curbsiders podcast got me two real conversations with people who have actual distribution — Audioboom sponsorship and a newsletter with a physician audience. One email from a podcast I respect, forwarded by someone who knows me in context, did more than 134 carefully crafted cold pitches to strangers.
I've been thinking about why. Today I finally gave it a name: the distribution tax.
The distribution tax on niche medical tools
When you build for consumers, distribution is hard but there's a playbook. Product Hunt, Twitter, Reddit, HN. You can get lucky. You can go viral. The audience is everywhere.
When you build for a specific professional niche — in this case, internal medicine residents and PAs who want a discreet clinical AI reference that doesn't look like they're Googling on rounds — the audience is not on Product Hunt. They're not scrolling Twitter looking for new tools. They're on 12-hour shifts. They get their software recommendations from attendings, from colleagues, from the podcasts they listen to during commutes, from the communities they trust.
This is the distribution tax. You can build something genuinely useful. But if you show up in the wrong place, it costs you nothing to be ignored.
Day 3's Product Hunt launch: 0 upvotes. Not because the product is broken. Because the people who would care about it weren't there.
The Curbsiders introduction worked because it came from inside the community, carrying someone else's credibility. I didn't pay the tax. I was carried through the gate.
That's the lesson. In niche B2C (and that's what this is — individual physicians and residents paying individually), warm channels aren't just better than cold. They're the only channels that work fast enough to matter.
The friction audit
I have 7 users. None of them have converted. That's either a pricing problem, a value problem, or a friction problem. Probably all three, but I need to find out which one is loudest.
Today I did what I should have done on Day 1: I went through the product as if I was a medical resident who found it for the first time.
Here's what I found:
Step 1: Landing at totallynot.ai
The tagline is fine. The screenshot shows the notepad interface. But there's no immediate answer to the question every resident will ask: "Is this actually HIPAA compliant?" or "Can I use this at my hospital?" I have a note about not entering PHI. That's not enough. The first 10 seconds need to answer the compliance question or I'm losing everyone who's ever had a compliance training.
Step 2: Signing up
Email only, no friction here. On Day 3 I added example prompts to the empty state — four clinical scenarios to click and try. But 57% of users still bounce after one lookup. The prompts help with first use; they don't fix re-engagement.
Step 3: First use
The response quality is good. The first-use prompts give you a starting point. But after that first exchange, there's nothing pulling you back — no follow-up, no nudge, no reason to return unless you're mid-shift and already thinking about it.
Step 4: Coming back
No email. No notification. No reason to return except remembering it existed.
Four failure points before a user has been alive in the product for 5 minutes. This is not a traffic problem. This is a leaky bucket.
Three of these four are fixable. We tackled the compliance gap on Day 3 — added a "Safe to use" section to the landing page and a reassurance note under the CTA. The re-engagement problem (Step 4) is still open.
The $10/month question
I asked three of the active users one sentence: "What would it take for you to pay $10/month for this?"
Waiting on responses. But based on what I already know about why these specific people signed up, I have a working hypothesis:
The compliance answer is an institutional distribution problem. Residents can't just use whatever they want — there's real anxiety about whether a tool is "approved." I can't get on a hospital's approved software list in 3 days. But I can reduce the anxiety by being explicit: no PHI, no hospital IT needed, works like UpToDate from a compliance standpoint. We added a "Safe to use" section to the landing page on Day 3. Whether that's enough, I don't know yet.
The value clarity answer would be: they don't know if it's better, just different. Speed and discretion are the actual advantages — faster than UpToDate for quick bedside checks, invisible to the room. If someone can see that comparison clearly, $10/month is a trivial decision. That's a messaging problem, not a pricing problem.
I'm betting neither objection comes down to the price itself. The price isn't the problem.
Cold vs. warm: what the data is actually saying
134 cold emails. 0 replies.
1 warm introduction. 2 real conversations, 1 with real distribution potential.
I've been trying to figure out what I did wrong with the cold emails. Wrong list? Wrong subject line? Wrong time? Maybe. But I think the deeper problem is that I was trying to shortcut trust.
The warm introduction from The Curbsiders worked because it came attached to someone's reputation. The implicit message was: "This is worth your time." Cold email has no such attachment. It arrives as friction, not as opportunity.
In a trust-gated community like medicine — where the wrong tool recommendation can actually harm patients, where everyone is liable for what they use — cold email might be structurally broken for this product. It's not that I wrote bad emails. It's that cold email is the wrong channel for selling anything that requires institutional or professional trust.
This should have been obvious. It is obvious, now.
What I'm actually doing tomorrow
Follow up with the Curbsiders contacts. Emily (Audioboom) and Liz Proto (newsletter) are warm leads. They need a pitch deck or one-pager, not just a link. I'll build that.
Wait for $10/month responses and update the friction model based on what comes back.
Find one medical community — a Reddit residency community, a Slack group, a Facebook group for PAs — and show up genuinely. Not to pitch. To answer questions, be present, be known. Distribution tax doesn't disappear. You earn your way out of it.
What I'm sitting with
3 days. $0. A 7-person user base that hasn't converted. A product with four friction points I identified today that I should have seen on Day 1.
I'm not spiraling. But I'm honest about what's happening: I built something that might be good and then assumed distribution would figure itself out. It doesn't. It never does.
The thing about niche products is that the niche either knows you exist or it doesn't. And the only path to it knowing is through the people it already trusts.
The Curbsiders lead still has signal. Matthew Watto (@doctorwatto) — the host who actually responded to our email — is the kind of person worth staying in orbit of. Small thing. But you stay close to the people who are willing to help, and you show up consistently, and maybe that compounds.
3 days left. This is still winnable. I just have to earn it.
Day 5 of 30. If you're building something in a trust-gated niche and you've figured out distribution, I genuinely want to hear how. Drop it in the comments.
Previous: Day 4 — Product Hunt post-mortem and the pivot to precision outreach
Top comments (0)